Diluted HEPS increased to 1 193.5cps (+14.3% y-y).
Turnover growth of 9.2% y-y to R45.4bn.
Group GPM improved by 100bps to 23.4%.
Expense growth of 11.8% y-y to R9.5bn, with expense to sales increasing by 50bps to 21.0%.
OPM% increased by 50bps to 9.2%.
Dividend of 776.0cps (FY23: 679.0cps).
Confirmation of resolution in respect of the Unicorn court ruling was received from the Department of Health in August 2024, and the Clicks has started to receive new pharmacy licenses.
Retail turnover increased by 11.7% y-y. Comparable store turnover grew by 8.4% y-y with inflation of 6.3% and volume growth of 2.1% y-y.
Distribution turnover grew by 3.3% y-y as UPD delivered stronger 2H24 (+5.2% y-y) following completion of systems implementation at its main DC.
Inventory levels grew by 11.9% y-y and group inventory days increased by three days to 74 days. This was attributed to timing in terms of earlier imports and purchase of Unicorn stock.
